Ünver Tuhan, H. Et Al. 2024. Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?. The 62nd Annual ESPE Meeting 2024 , (Liverpool, England), 368.

Ünver Tuhan, H., Singin, B., Donbaloğlu, Z., Özdem, S., & Parlak, M., (2024). Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children? . The 62nd Annual ESPE Meeting 2024 (pp.368). Liverpool, England

Ünver Tuhan, HALE Et Al. "Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?," The 62nd Annual ESPE Meeting 2024, Liverpool, England, 2024

Ünver Tuhan, HALE Ü. Et Al. "Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?." The 62nd Annual ESPE Meeting 2024 , Liverpool, England, pp.368, 2024

Ünver Tuhan, H. Et Al. (2024) . "Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?." The 62nd Annual ESPE Meeting 2024 , Liverpool, England, p.368.

@conferencepaper{conferencepaper, author={HALE ÜNVER TUHAN Et Al. }, title={Can asprosin be used as a diagnostic biomarker for non-alcoholic fatty liver disease in obese children?}, congress name={The 62nd Annual ESPE Meeting 2024}, city={Liverpool}, country={England}, year={2024}, pages={368} }